c.9253-6T>c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome

Overview of attention for article published in Hematology Transfusion and Cell Therapy, June 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,877 followers.

c.9253-6T>c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome. https://t.co/krhwpPTYDd https://t.co/jXruKGHUPx

New article: c.9253-6T>c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome. https://t.co/tKDUDvL7km #AML #leusm #hematology https://t.co/jLtISd5GOJ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.